Lupi HE, Gaspar J, González PH, Martínez SC, Pastelín HG, Luna OP, Chávez CE

Language: Spanish
References: 117
Page: 76-101
PDF size: 250.97 Kb.

ABSTRACT

After prolonged periods of ischemia and energy depletion, the ischemic myocardial cell can be jeopardized by specific causes within the reperfusion period. These causes can be viewed as unwanted aspects of the recovery process itself limiting its efficiency. Three potential initial causes of immediate reperfusion injury, aside from oxygen radicals, have been experimentally investigated in detail, and are briefly discussed: 1. re-energization; 2. rapid normalization of tissue pH; and 3. rapid normalization of tissue osmolality. These potential causes are not entirely independent. Understanding of the basic causes has opened novel perspectives for specific interference with these serious pathomechanisms. The experimental results obtained in the last years encourage the development of therapeutic approaches to reduce infarct size by specific measures applied during the early phase of reperfusion. In the clinical setting, reperfusion therapy for acute myocardial infarction (AMI) has shown to reduce mortality, yet it may also have deleterious effects, including myocardial necrosis and no-reflow. Almost two decades ago, great hope arose from the description of ischemic preconditioning. Unfortunately, ischemic preconditioning is not feasible in the clinical practice because the coronary artery is already occluded at the time of hospital admission of the AMI patient. Recently, in the dog model, a phenomenon called “postconditioning” has been described. It has been reported previouly that reperfusion injury can be significantly reduced by modifying the conditions and the composition of the initial reperfusate. Whereas preconditioning is triggered by brief episodes of ischemia-reperfusion performed just before a prolonged coronary artery occlusion, postconditioning is induced by a comparable sequence of reversible ischemia–reperfusion, but it is applied “just after the prolonged” ischemic insult. Protection afforded by postconditioning is as potent as that provided by preconditioning. Unlike preconditioning, the experimental design of postconditioning allows direct application in the clinical practice, especially during PTCA. It has been reported very recently, that postconditioning patients with ST segment elevation AMI, during coronary angioplasty protects the human heart in this clinical scenario. Obtaining such a beneficial effect by a simple manipulation of reperfusion is of major potential clinical interest. Now more than ever, mechanistic and pharmacological research in the field of reperfusion injury appears to be necessary and clinically relevant.

REFERENCES

1. Lupi HE, González PH, Juárez UH, Chuquiure E, Vieyra G, Martínez SC: La meta de la reperfusión en los síndromes isquémicos coronarios agudos con elevación del segmento ST. «Lo que hay más allá del flujo TIMI 3 epicárdico». Arch Cardiol Mex 2002; 72: 311-349.

2. Jennings RB, Reimer KA: Factors involved in salving ischemic myocardium effect of reperfusion of arterial blood. Circulation 1983; I25-I-36.

3. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Intravenous streptokinase given 0-4 hours of onset of myocardial infarction reduced mortality in ISIS-2. Lancet 1987; 1: 502.

4. McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom AR, Blackburn H, Luepker RV: Recent trials in acute coronary disease mortality, morbidity, medical care and risk factors: The Minnesota Heart Survey Investigators. N Engl J Med 1996; 334: 884-890.

5. Thompson PL, Fletcher EE, Katavatis V: Enzymatic indices of myocardial necrosis: influence on short —and long—term prognosis after myocardial infarction. Circulation 1979; 59: 113-119.

6. Braunwald E: Myocardial reperfusion ,limitations of infarct size, reduction of left ventricular dysfunction and improved survival: should the paradigm be expanded? Circulation 1989; 79: 441-444.

7. Braunwald E, Kloner RA: Myocardial reperfusion: a double –edge sword? J Clin Invest 1985; 76: 1713–1719.

8. Piper HM, García-Dorado D, Ovize M: A fresh look at reperfusion injury. Cardiovasc Res 1998; 38: 291–300.

9. Kloner RA: Does reperfusión injury exist in humans ? J Am Coll Cardiol 1993; 21: 537-545.

10. Ferrari R, Hearse DJ: Reperfusion injury: does it exist and does it have clinical relevanc? J Thromb Thrombol 1997; 4: 25–34.

11. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.

12. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J: Inhibition of myocardial injury by ischemic post-conditioning during reperfusion: comparison with ischemic preconditioning . Am Physiol Heart Circ Physiol 2003; 285: H579-H588.

13. Staat P, Rioufol G, Piot C, Cottin Y, Tri Cung T, l´Huilier I, et al: Postconditioning the human heart. Circulation 2005; 112: 2143-2148.

14. Bolli R: Myocardial stunning in man. Circulation 1992; 86: 1671-1691.

15. Hearse DJ, Humphrey SM, Chain EB: Abrupt reoxygenation of the anoxic potassium –arrested perfused rat heart: a study of myocardial injury. J Moll Cell Cardiol 1983; 15: 67-73.

16. Ganote CE: Contraction band necrosis and irreversible myocardial injury. J Moll Cell Cardiol 1983; 15: 67-73.

17. Ganote CE, Vander Heide RS: Importance of mechanical factors in ischemic and reperfusion injury. En: Piper HM (Ed.) Pathophysiology of severe ischemic myocardial injury. Dordrecht: Kluwer, 1990: 337-355.

18. Siegmund B, Zude R, Piper HM: Recovery of -anoxic reoxygenated cardiomyocytes from severe calcium overload. Am J Physiol 1992; 263: H1262-H1269.

19. Siegmund B, Koop A, Klietz T, Schwartz P, Piper HM: Sarcolemmal integrity and metabolic competence of cardiomyocytes under anoxia –reoxygenation. Am J Physiol 1990; 258: H285-H291.

20. Siegmund B, Klietz T, Schwartz P, Piper HM: Temporary contractile blockade prevents hypercontracture in anoxic –reoxygenated cardiomyocytes. Am J Physiol 1991; 260: H426-H435.

21. Ladilov YV, Siegmund B, Piper HM: Simulated ischemia increases the susceptibility of rat cardiomyocytes to hypercontracture. Circ Res 1997; 80: 69-75.

22. Gao WD, Liu Y, Mellgren R, Marban E: Intrinsic myofilament alterations underlying the decreased contractility of stunned myocardium. A consequence of Ca2+ –dependent proteolysis? Circ Res 1996; 78: 455-465 .

23. Siegmund B, Schlack W, Piper HM: Halothane protects cardiomyocytes against reoxygenation–induced hypercontracture. Circulation 1997; 96: 4372-4379.

24. Schlack W, Hollmann M, Stunneck J, Thämer V: Effect of halothane on myocardial reoxygenation injury in the isolated rat heart. Br J Anaesth 1996; 76: 860-867.

25. Preckel B, Schlak W, Comfëre T, Borthel H, Thämer V: Effects of inhalation anaesthetics on myocardial reperfusion injury in vivo. Pflügers Arch 1997; 433: R15.

26. Ladilov YV, Siegmund B, Piper HM: Protection of the reoxygenated cardiomyocyte against hypercontracture by inhibition of Na+/H+ exchange. Am J Physiol 1995; 268: H1531-H1539.

27. Bugge E, Ytrehus K: Inhibition of sodium –hydrogen exchange reduces infarct size in the isolated rat heart –a protective additive to ischemic preconditioning . Cardiovasc Res 1995; 29: 269-274.

28. Klein HH, Pich S, Bohle RM, Wollenweber J, Nebendahl K: Myocardial protection by Na+/H+ exchange inhibition in ischemic reperfused porcine hearts. Circulation 1995; 92: 912-917.

29. García –Dorado D, González MA, Barrabés JA, Ruiz –Meana M, Solares J, Lidón RM, et al: Prevention of ischemic rigor occlusion by inhibition of Na+ – H+ exchange. Cardiovasc Res 1997; 35: 80-89.

30. Inserte J, García –Dorado D, Ruiz-Meana M, Solares J, Soler-Soler J: The Na+ – H+ exchange occurring during hypoxia in the genesis of reoxygenation –induced myocardial oedema. J Moll Cell Cardiol 1997; 29: 1167-1175.

31. García –Dorado D, Oliveras J: Myocardial edema: a preventable cause of reperfusion injury. Cardiovasc Res 1993; 27: 1555—563.

32. Schlüter KD, Jakob G, Ruiz-Meana M, García –Dorado D, Piper HM: Protection of reoxygenated cardiomyocytes against osmotic fragility by NO donors. Am J Physiol 1996; 271: H428-H434.

33. Ruiz-Meana M, García-Dorado D, González MA, Barrabés JA, Soler-Soler J: Effects of osmotic stress on sarcolemmal integrity of isolated cardiomyocytes following transient metabolic inhibition. Cardiovasc Res 1995; 30: 64-69.

34. Kloner RA, Reimer KA, Willerson JT, Jennings RB: Reduction of experimental myocardial infarct size with hyperosmotic mannitol. Proc Soc Exp Biol Med 1976; 151: 677-683.

35. Ganote CE: Cell-to-cell interactions contributing to the oxygen paradox. Bas Res Cardiol 1985; 80: 141-146 .

36. Frank JS, Brandy AJ, Fransworth BS, Mottino G: Ultrastructure and function of isolated myocytes after calcium depletion and repletion. Am J Physiol 1986; 250: H265-H275.

37. Fliss H, Gattinger D: Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996;79: 949-956.

38. Veinot JP, Gattinger DA, Fliss H: Early apoptosis in human myocardial infarcts. Hum Pathol 1997; 28: 485-492.

39. Gotttlieb RA, Burleson KO, Kloner RA , Babior BM, Engler RL: Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94: 1621-1628.

40. Buckberg GD: Myocardial protection : an overview. Semin Thorac Cardiovasc Surg 1993; 5: 98-106.

41. Vinten-Johansen J, Edgerton TA, Howe HR, Gayheart PA, Mills SA, Howard G, Cordell AR: Immediate functional recovery and avoidance of reperfusion injury with surgical revascularization of short-term coronary occlusion. Circulation 1985; 72: 431-439.

42. Okamoto F, Allen BS, Buckberg GD, Buyi H, Leaf J: Reperfusion conditions: importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion. J Thorac Cardiovasc Surg 1986; 92: 613-620.

43. Vinten-Johansen J, Yellon DM, Opie LH: Postconditioning. A simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation 2005; 112: 2085-2088.

44. Sato H, Jordan JE, Zhao ZQ, Sarvotham SS, Vinten-Johansen J: Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation. Ann Thorac Surg 1997; 64: 1099-1107.

45. Vinten-Johansen J, Lefer DJ, Nakanishi K, Johnston WE, Brian CA, Cordell RA: Controlled coronary hydrodynamics at the time of reperfusion reduces postischemic injury. Coron Artery Dis 1992; 3: 1081-1093.

46. Tsao PS, Aoki N, Lefer DJ, Johnson G III, Lefer AM: Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 1990; 82: 1402-1412.

47. Piper HM, Schafer AC: The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 2004; 61: 365-371.

48. Zweir JL, Flaherty JT, Weisfeldt ML: Direct measurement of free radicals generated following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 1987; 84:1404-1407.

49. Schwartz LM: Ischemic Postconditioning during reperfusión fails to protect against lethal myocardial ischemia –reperfusion injury in pigs. Circulation 2004; 110: III-106.

50. Farber NE, Pieper GM, Gross GJ: Postischemic recovery in the stunned myocardium after reperfusion in the presence or absence of a flow-limiting coronary artery stenosis. Am Heart J 1988; 116: 407-420.

51. Granato JE, Watson DD, Flanagan TL, Gascho JA, Beller GA: Myocardial thallium –201 kinetics during coronary occlusion and reperfusion: influence of method of reflow and timing of thallium –201 administration. Circulation 1986; 73: 150-160.

52. Granato JE, Watson DD, Flanagan TL, Beller GA: Myocardial thallium-201 kinetics and regional flow alterations with 3 hours of coronary occlusion and either rapid reperfusion through a critical stenosis. J Am Coll Cardiol 1987; 9: 109-118

53. Yamazaki S, Fujibayashi Y, Rajagopalan RE, Meerbaum S, Corday E: Effects of staged versus sudden reperfusion after acute coronary occlusion in the dog. J Am Coll Cardiol 1986; 7: 564-572.

54. Hori M, Kitakaze M, Sato H, Takashima S, Iwakura K, Inoue M, et al: Staged reperfusion attenuates myocardial stunning in dogs: role of transient acidosis during early reperfusion. Circulation 1991; 84: 2135–2145.

55. Kuzuya T, Hoshida S, Yamshita N, Fuji H, Oe H, Hori M, Kamada T, Tada M: Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993; 72: 1293-1299.

56. Becker LC, Ambrosio G, Manissi J, Weisman HF: The no-reflow phenomenon: a misnomer? En: Analysis and simulation of the cardiac system – ischemia. Ed: Sideman S . Boca Ratón: CRC Press, 1989: 189-309.

57. Toombs CF, McGee DS, Jonhston WE, Vinten-Johansen J: Myocardial protective effects of adenosine: infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 1992; 86: 986-994.

58. Glower DD, Schaper J, Kabas JS, Hoffmeister HM, Schaper W, Spratt JA, et al: Relation between reversal of diastolic creep and recovery of systolic function after ischemic myocardial injury in conscious dogs. Circ Res 1987; 60: 850-860.

59. Kroemer G, Dallaporta B, Resche –Rigon M: The mitocondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 1998 ; 60 : 619-642.

60. Griffiths EJ, Halestrap AP: Mitochondrial non-specific pores remain closed during cardiac ischemia, but open upon reperfusion. Biochem J 1995; 307: 93-98.

61. Griffiths EJ, Halestrap AP: Protection by Cyclosporin A of ischemia/reperfusion –induced damage in isolated rat hearts. J Moll Cell Cardiol 1993; 25: 1461-1469.

62. Xu M, Wang Y, Hirai K, Ayub A, Ashraf M: Calcium preconditioning inhibits mitocondrial permeability transition and apoptosis. Am J Physiol Heart Circ Physiol 2001; 280: H899-H908.

63. Arteaga D, Odor A, López RM, Contreras G, Pichardo J, García E, Arnada A, Chávez E: Impairments by cyclosporin A of reperfusion –induced arrhythmias. Life Sci 1992; 51: 1127-1134.

64. Argaud L, Gateau –Roesch O, Raisky O, Loufouat J, Robert D, Ovize M: Postconditioning inhibits mitocondrial permeability transition. Circulation 2005; 111: 194-197.

65. Hausenloy D, Wynne A, Duchen M, Yellon DM: Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 2004; 109: 1714-1717.

66. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM: Postconditioning: a form of «modified reperfusion» protects the myocardium by activating the phosphatidylinositol 3-kinase Akt pathway. Circ Res 2004; 95: 230-323.

67. Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV: Multiple, brief coronary occlusions during early reperfusion protects rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 2004; 44: 1103-1110.

68. Hausenloy DJ, Yellon DM: New directions for protecting the heart against ischemia-reperfusion injury: targeting the reperfusion injury salvage kinase [RISK] pathway. Cardiovasc Res 2004; 61: 448-460.

69. Sun HY, Wang NP, Kerendi F, Halkos M, Kin H, Guyton RA, Vinten-Johansen J, Zhao ZQ: Hypoxic Postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol 2005; 288: 1900-1908.

70. Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, Kerendi F, Guyton RA, Vinten-Johansen J: Postconditioning attenuates myocardial ischemia – reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 2004; 62: 74-85.

71. Zhao ZQ, Sun HY, Wang NP, Kerendi F, Guyton RA, Vinten-Johansen J: Hypoxic Postconditioning reduces cardiomyocytes loss by inhibiting reactive oxygen species –triggered mitochondrial calcium overload. Circulation 2003: 108(Suppl IV ): 174.

72. Yang X, Downey JM, Cohen MV: Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by activation of ERK and production of nitric oxide. Circulation 2003; 108[ Suppl IV]: 158.

73. Tsuruta F, Masuyama N, Gotoh Y: The phosphatidylinositol 3-kinase (PI3K)–Akt pathway suppresses Bax translocation to mitochondria. J Biol Chem 2002; 277: 14040-14047.

74. Balakirev MY, Khamtsov VV, Zimmer G: Modulation of the mitochondrial permeability transition by nitric oxide. Eur J Biochem 1997; 246: 710-718.

75. García-Dorado D, Piper HM: Postconditioning: Reperfusión of «Reperfusión injury» after hibernation. Cardiovasc Res 2006; 69: 1-3.

76. Buckberg GD: Studies of controlled reperfusion after ischemia: I. When is cardiac muscle damaged irreversibly? J Thorac Cardiovasc Surg 1986; 92: 483-487.

77. Rentrop KP, Cohen M, Blanke H, Phillips RA: Changes in collateral channel filling immediately after controlled coronary occlusion by an angioplasty balloon on human subjects. J Am Coll Cardiol 1985; 5: 587-592.

78. Galagudza M, Kurapeev D, Minasiana S, Valen G, Vaage J: Ischemic postconditioning: brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm. Eur J Cardiovasc Surg 2004; 25: 1006-1010.

79. Halkos ME, Kerendi F, Corvera JS, Wang NP, Kin H, Payne CS, et al: Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg 2004; 78: 961-969.

80. Kloner RA, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, et al for the TIMI 4 Investigators: Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning? . Circulation 1995; 91: 37-45.

81. Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D, Rusticali F: Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation 1995; 91: 291-297.

82. Feild BJ, Russell RO, Dowling JT, Rackley CE: Regional left ventricular performance in the year following myocardial infarction. Circulation 1972; 46: 679-689.

83. Rogers WJ, McDaniel HG, Smith LR, Mantle JA, Russell RO, Rackley CE: Correlation of angiographic estimates of myocardial infarct size and accumulated release of creatine kinase MB isoenzyme in man. Circulation 1977; 56: 199-205.

84. Lapeyre AC, Gibson WS, Bashore TM, Gibbons RJ: Quantitative regional wall motion analysis with early contrast ventriculography for the assessment of myocardium at risk in acute myocardial infarction. Am Heart J 2003; 145: 1051-1057.

85. Vivaldi MT, Kloner RA, Schoen FJ: Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol 1985; 121: 522-530.

86. Argaud L, Gateau-Roesch O, Chalabreysse L, Gómez L, Loufouat J, Thivolet-Bejui F, et al: Preconditioning delays Ca2+ induced mitochondrial permeability transition. Cardiovasc Res 2004; 61: 115-122.

87. van´t–Hof AWJ, Liem A, Suryapranata H, Hoorntje JCA, De Boer MJ, Zijlstra F, for the Zwolle Myocardial Infarction Study Group: Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade . Circulation 1998; 97: 2302-2306.

88. Poli A, Fetiveau R, Vandoni P, Del Rosso G, D´Urbano M, Seveso G, Cafiero F, De Servi S: Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty real-time grading of microvascular reperfusion and perfusion of early and late recovery of left ventricular function. Circulation 2002; 106: 313-318.

89. Rochitte CE, Lima JA, Bluemke DA, Reeder SB, Mc Veigh ER, Furuta T, et al: Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998; 98: 1006-1014.

90. Mahaffey KW, Puma JA, Barbagelata NA, DiCarli MF, Leesar MA, Browne KF, et al: Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a Multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction Study of Adenosine (AMISTAD) trial. J Am Coll Cardiol 1999; 34: 1711-1720.

91. Téllez JF, Carvajal K, Cruz D, Carabez A, Chavez E: Effect of perezone on arrhythmias and markers of cell injury during reperfusion in the anesthetized rat. Life Sci 1999; 65: 1615-1623.

92. Chávez E, Téllez F, Pichardo J, Milán R, Cuéllar A, Carbajal K, Cruz D: On the protection by ketorolac of reperfusion –induced heart damage. Comp Biochem Physiol 1996; 115C: 95-100.

93. Parra E, Cruz D, García G, Zazueta C, Correa F, García N, Chávez E: Myocardial protective effect of octylguanidine against the damage induced by ischemia reperfusión in rat heart. Moll Cell Biochem 2005; 269: 19-26.

94. Chávez E, Peña A, Zazueta C, Ramírez J, García N, Carrillo R: Inactivation of mitochondrial permeability transition by octylguanidine and octylamine. J Bioenerg Biomembr 2000; 32: 193-198.

95. Bobadilla I, Franco M, Cruz D, Zamora J, Robles SG, Chávez E: Hypothyroidism provides resistance to reperfusion injury following myocardial ischemia. Int J Biochem Cell Biol 2001; 33: 499-506.

96. Inserte J, García–Dorado D, Heranado V, Soler-Soler J: Calapain –mediated impairment of Na+/K+ -ATPase activity during early reperfusion contributes to cell death after myocardial ischemia. Circ Res 2005; 97: 465-473.

97. Canyon SJ, Dobson GP: Pretreatment with an adenosine A1 receptor agonist and lidocaine : A possible alternative to myocardial ischemic preconditioning . J Thorac Cardiovasc Surg 2005; 130: 371-377.

98. Kerensky RA, Kutcher MA, Braden GA, Applegate RJ, Solis GA, Little WC: The effects of intracoronary adenosine on preconditioning during coronary angioplasty. Clin Cardiol 1995; 18: 91-96.

99. Leesar MA, Stoddard M, Ahmed M, Broadbent J, Bolli R: Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 1997; 95: 2500-2507.

100. Assali AR, Sdringola S, Ghani M, Denkats AE, Yepes A, Hanna GP, et al: Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of «no reflow» phenomenon. Cathet Cardiovasc Intervention 2000; 51: 27-31.

101. Kloner RA, Rezkalla SH: Cardiac protection during acute myocardial infarction: Where do we stand in 2004? J Am Coll Cardiol 2004; 44: 276-286.

102. Bell SP, Sack MN, Patel A, Opie LH, Yellon DM: Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol 2000; 36: 2296-2302.

103. Kato R, Föex P: Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologist. Can J Anesth 2002; 49: 777-791.

104. Xenopoulos NP, Leesar M, Bolli R: Morphine mimics ischemic preconditioning in human myocardium during PTCA. J Am Coll Cardiol 1998; 31: 65A.

105. Weihrauch D, Krolikowski JG, Bienengraeber M, Kersten JR, Warltier DC, Pagel PS: Morphine enhances isoflurane-induced postconditioning against myocardial infarction : the role of phosphatidylinositol-3-kinase and opioid receptors in rabbits. Anesth Analg 2005; 101: 942-949.

106. Zazueta C, Zafra G, Vera G, Sánchez C, Chávez E: Advances in the purification of the mitochondrial Ca2+ uniporter using the labeled inhibitor 103 Ru –360. J Bioenerg Biomembr 1998; 30: 489-498.

107. Zazueta C, Sosa-Torres ME, Correa F, Garza-Ortíz A: Inhibitory properties of ruthenium amine complexes on mitochondrial calcium uptake. J Bioenerg Biomembr 1999: 551-557.

108. García-Rivas GJ, Guerrero-Hernández A, Guerrero–Serna G, Rodríguez–Zavala J, Zazueta C: Inhibition of the mitochondrial calcium uniporter by the oxo-bridged dinuclear ruthenium amine complex [Ru-360] prevents from irreversible injury in postischemic rat heart. FEBS 2005; 272: 3477-3488.

109. Correa F, Zazueta C: Mitochondrial glycosidic residues contribute to the interaction between ruthenium amine complexes and the calcium uniporter. Mol Cell Biochem 2005; 272: 55-62.

110. Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003; 361: 13-20.

111. Nallamouthu BK, Bates ER: Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction. Am J Cardiol 2003; 92: 824-826.

112. Giugliano RP, Barunwald E: Selecting the best reperfusion strategy in ST-elevation myocardial infarction: it´s all matter of time. Circulation 2003; 108: 12828-2830.

113. RENASICA, Grupo cooperativo: El Registro Nacional de los Síndromes Isquémicos Coronarios Agudos (RENASICA I).Sociedad Mexicana de Cardiología. Arch Cardiol Mex 2002; 72: S45-S64.

114. Gersh BJ, Anderson JL: Thrombolysis and myocardial salvage: results of clinical trials and the animal paradigm –paradoxic or predictable? Circulation 1993; 88: 296-306.

115. Gersh BJ, Stone GW, White HD, Holmes DR: Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction. Is the slope of the curve the shape of the future. JAMA 2005; 293: 979-986.

116. Lupi HE, Lasses LA, Cosio AJ, Chuquiure EV, Martínez SC, Ortíz P, et al: Acute right ventricular infarction : clinical spectrum , results of reperfusion therapy and short-term prognosis. Coron Artery Dis 2002; 13: 57-64.

117. Hochman JS: Cardiogenic shock complicating acute myocardial infarction: Expanding the paradigm. Circulation 2003; 107: 2998-3002.